v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
License and other revenue $ 15,000 $ 0
Operating expenses:    
Research and development 33,443 22,652
General and administrative 12,334 13,438
Loss from operations (30,777) (36,090)
Interest and investment income 7,890 2,591
Interest expense (2,877) (2,529)
Other non-operating income (expense), net 1,026 (1,537)
Loss before income taxes (24,738) (37,565)
Income tax expense 1,397 481
Net loss (26,135) (38,046)
Other comprehensive (loss) income:    
Foreign currency translation adjustment 643 (25)
Unrealized gain on available for sale marketable securities, net of reclassification adjustment and tax (2,781) 155
Other comprehensive (loss) income (2,138) 130
Total comprehensive loss $ (28,273) $ (37,916)
Net loss per ordinary share - basic (in dollars per share) $ (0.20) $ (0.38)
Net loss per ordinary share - diluted (in dollars per share) $ (0.20) $ (0.38)
Weighted average ordinary shares outstanding - basic (in shares) 133,033,541 99,887,720
Weighted average ordinary shares outstanding - diluted (in shares) 133,033,541 99,887,720